Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enting

Showing results (191-200 of 232) with videos related to

Pageof 24
Sort By:
Brain Communications|August 8, 2024
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastomaJorien B E Janssen, Cyrillo G Brahm, Chantal M L Driessen, et al.
Nature Medicine|August 7, 2025
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trialMatthew D Galsky, Dean F Bajorin, Yoshihiko Tomita, et al.
Frontiers in Oncology|January 24, 2024
A cohort profile of the Graham Roberts study cohortBeth Russell, Poppy Leech, Harriet Wylie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2022
A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial CarcinomaSimon J Crabb, Syed Hussain, Eileen Soulis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 23, 2018
Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up studyCyrillo G Brahm, Martha W den Hollander, Roelien H Enting, et al.
Journal of Neuro-Oncology|October 29, 2013
Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivorsEsther J J Habets, Martin J B Taphoorn, Sylvie Nederend, et al.
Journal of Neuro-Oncology|June 19, 2024
Clusters of resilience and vulnerability: executive functioning, coping and mental distress in patients with diffuse low-grade gliomaFloor Gelmers, Marieke E Timmerman, Femke F Siebenga, et al.
Journal of Neuro-Oncology|July 22, 2017
Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysisMyra E van Linde, Cyrillo G Brahm, Philip C de Witt Hamer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Cognitive rehabilitation in patients with gliomas: a randomized, controlled trialKarin Gehring, Margriet M Sitskoorn, Chad M Gundy, et al.
Hematological Oncology|August 18, 2016
Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 studyJeanette K Doorduijn, Gustaaf W van Imhoff, Bronno van der Holt, et al.
Pageof 24

Showing results (191-200 of 232) with videos related to

Sort By:
Pageof 24
Brain Communications|August 8, 2024
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastomaJorien B E Janssen, Cyrillo G Brahm, Chantal M L Driessen, et al.
Nature Medicine|August 7, 2025
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trialMatthew D Galsky, Dean F Bajorin, Yoshihiko Tomita, et al.
Frontiers in Oncology|January 24, 2024
A cohort profile of the Graham Roberts study cohortBeth Russell, Poppy Leech, Harriet Wylie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2022
A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial CarcinomaSimon J Crabb, Syed Hussain, Eileen Soulis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 23, 2018
Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up studyCyrillo G Brahm, Martha W den Hollander, Roelien H Enting, et al.
Journal of Neuro-Oncology|October 29, 2013
Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivorsEsther J J Habets, Martin J B Taphoorn, Sylvie Nederend, et al.
Journal of Neuro-Oncology|June 19, 2024
Clusters of resilience and vulnerability: executive functioning, coping and mental distress in patients with diffuse low-grade gliomaFloor Gelmers, Marieke E Timmerman, Femke F Siebenga, et al.
Journal of Neuro-Oncology|July 22, 2017
Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysisMyra E van Linde, Cyrillo G Brahm, Philip C de Witt Hamer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Cognitive rehabilitation in patients with gliomas: a randomized, controlled trialKarin Gehring, Margriet M Sitskoorn, Chad M Gundy, et al.
Hematological Oncology|August 18, 2016
Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 studyJeanette K Doorduijn, Gustaaf W van Imhoff, Bronno van der Holt, et al.
Pageof 24